NCT04615390

Brief Summary

COVID19 patients survivors, after discharge from hospital show reduced lung function and reduced ability to exercise. Furthermore, mental health problems including stress, anxiety and depression and a low quality of life were observed. The prospective observational study involves COVID19 patients who have needed rehabilitation at the University Hospital of Ferrara. Patients receive comprehensive rehabilitation based on their specific needs in both acute and subacute rehabilitation. At the end of hospital rehabilitation, patients are offered a program to be carried out at home for both physical and psychological problems. A range of demographic and clinical data will be collected. Patients will also undergo a battery of functional, cognitive and psychological tests at 12, 26 and 52 weeks from the infection onset. Moreover, a specific assessement (both clinical and instrumental) on the pain symptom experienced, where present, will be done.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 30, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 29, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 4, 2020

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
Last Updated

January 13, 2023

Status Verified

January 1, 2023

Enrollment Period

3.3 years

First QC Date

October 29, 2020

Last Update Submit

January 11, 2023

Conditions

Keywords

covid19rehabilitationmindfulnessfunctional recoverypsychological well-beingpainpost covid syndrome

Outcome Measures

Primary Outcomes (25)

  • Borg scale

    Rating perceived exertion on a 10-points scale in which higher values correspond to havier symptomps.

    At the beginning of early rehabilitation

  • Heart rate

    Heart rate in sitting and standing positions.

    At the beginning of early rehabilitation

  • Oxygen saturation

    Oxygen saturation in sitting and standing positions.

    At the beginning of early rehabilitation

  • 30 seconds sit-to-stand test

    To measure the strength of the lower limbs.

    At the beginning of early rehabilitation

  • Change in 1 minute sit-to-stand test between two time points

    To measure the strength of the lower limbs.

    Month 3, Month 6

  • Change in Short form health survey between three time points

    Is a general health questionnaire for the assessment of the patient's quality of life. Two summary scores are reported: a mental component score and a physical component score. The scores may be reported as Z-scores.

    At the beginning of early rehabilitation, Month 3, Month 6

  • 2-minute walking test

    For mobility assessment

    At the beginning of early rehabilitation

  • Change in 6-minute walking test between two time points

    For mobility assessment

    Month 3, Month 6

  • Change in Functional Independence Measure Scale between two time points

    Evaluate the functional autonomy of the patient both on the motor and cognitive side (minumum score:18 maximum score:126 ). At 3 months the "FIM efficiency" is evaluated as a measure of the efficiency of the rehabilitation intervention.

    At the beginning of early rehabilitation, Month 3

  • Change in Montreal Cognitive Assessment (MoCA) between two time points

    Cognitive screening test. Higher scores (0-30) are related to a better performance.

    Month 3, Month 6

  • Cognitive Reserve Index questionnaire

    For measuring cognitive reserve. It comprehends a overall evaluation of the subject's cognitive status based on social and personal data. Higher scores underline major cognitive reserves.

    Month 3

  • Change in Patient Health Questionnaire-9 (PHQ-9) between two time points

    To identify the presence of depression and measure its severity. Score goes from 0 to 27 in which higer numbers represent worse clinical outcomes.

    Month 3, Month 6

  • Change in Beck Anxiety Inventory (BAI) between two time points

    To measure the severity of anxiety. Higher scores (0-63) indicates more severe anxiety symptoms

    Month 3, Month 6

  • Change in Connor-Davidson Resilience Scale between two time points

    To measure the resilience. Total score goes from 0 to 40, higher points mean greater resilience.

    Month 3, Month 6

  • Change in Impact of Event Scale - Revised between two time points

    To measure the amount of distress that associate with a specific event. Total score varies from 0 to 88, higher scores indicate greater post-event distress.

    Month 3, Month 6

  • Change in General Self Efficacy Scale between two time points

    To assess how much people believe they can achieve their goals, despite difficulties. Total score could be from 4 to 40, higher results show larger self efficacy perception.

    Month 3, Month 6

  • Change in Pittsburgh Sleep Quality Index (PSQI) between two time points

    To assess sleep quality. Higher scores are related to a worse sleep quality.

    Month 3, Month 6

  • Covid19 Yorkshire Rehabilitation Scale (C19-YRS)

    Clinical interview (qualitative evaluation) for investigating perceived outcomes after the acute phase of the pathology.

    Referred changes between 3, 6 and 12 months after the symtomps onset

  • Changes on pain intensity assessed with a Numeric Rating Scale (NRS) between three time points

    To estimate the amount of pain perceived through a numerical classification in which higher scores indicate greater pain intensity

    Month 3, Month 6, Month 12

  • Changes in Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) score between three time points

    To investigate neuropathic charateristics of pain. The global score goes from 0 to 24, over 12 points it is palusible the presence of neuropathic mechanism.

    Month 3, Month 6, Month 12

  • Changes in Central Sensitization Inventory (CSI) score between three time points

    To detect the presence of central sensitization (score between 0-100 in which higher scores suggest the presence of central sensitization)

    Month 3, Month 6, Month 12

  • Pressure Pain Threshold (PPT)

    Changes assessed with an algometer on upper trapezius and rectus femoris bilaterally

    Month 3, Month 6, Month 12

  • Temporal Summation (TS)

    Changes assessed with an algometer on upper trapezius and rectus femoris bilaterally

    Month 3, Month 6, Month 12

  • Changes in Pain Catastrophizing Scale (PCS) score between three time points

    To examine the pain experience felt

    Month 3, Month 6, Month 12

  • Changes in Tampa Scale of Kinesiophobia (TSK) score between three time points

    For detecting the pain consequences on movement and related beliefs

    Month 3, Month 6, Month 12

Interventions

The intervention is primarily focused on the recovery of mobility and functional autonomy. The treatment sessions are dependent on the patient's exercise tolerance.

Comprehensive intensive rehabilitation in the hospital

The home mindfulness training consists of 2 parts: 1) explanation and reflection of the Mindfulness practice 2) formal and informal practice.

Low-intensity walking exercises at home

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

People infected with COVID-19 and healthy subjects matched for age and sex (pain assessment).

You may qualify if:

  • diagnosis of covid19 (WHO criteria);
  • indication for respiratory and / or neuromotor rehabilitation treatment

You may not qualify if:

  • cognitive or communication impairment precluding informed consent
  • severe medical conditions
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neuroscience and Rehabilitation, University Hospital of Ferrara

Ferrara, Emilia-Romagna, 44124, Italy

RECRUITING

MeSH Terms

Conditions

COVID-19Psychological Well-BeingPain

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPersonal SatisfactionBehaviorNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Sofia Straudi, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

October 29, 2020

First Posted

November 4, 2020

Study Start

March 30, 2020

Primary Completion

June 30, 2023

Study Completion

November 30, 2023

Last Updated

January 13, 2023

Record last verified: 2023-01

Locations